Citigroup
HSTO

Citigroup’s Histogen Inc. Common Stock HSTO Stock Holding History

Citigroup’s Portfolio HSTO Stock Details HSTO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-5
Closed – – 6495
2021
Q2 		$0 Hold
5
– – ﹤0.01% 6548
2021
Q1 		$0 Hold
5
– – ﹤0.01% 7754
2020
Q4 		$0 Hold
5
– – ﹤0.01% 7720
2020
Q3 		$0 Hold
5
– – ﹤0.01% 7678
2020
Q2 		$0 Sell
5
-22
-81% -$1.85K ﹤0.01% 7756
2020
Q1 		$1K Hold
27
– – ﹤0.01% 7549
2019
Q4 		$2K Hold
27
– – ﹤0.01% 7576
2019
Q3 		$1K Sell
27
-50
-65% -$3.26K ﹤0.01% 7650
2019
Q2 		$4K Buy
77
+30
+64% +$5.21K ﹤0.01% 7550
2019
Q1 		$10K Buy
47
+26
+124% +$10.5K ﹤0.01% 7263
2018
Q4 		$8K Sell
21
-137
-87% -$106K ﹤0.01% 7249
2018
Q3 		$183K Sell
158
-26
-14% -$24K ﹤0.01% 5356
2018
Q2 		$158K Buy
184
+134
+268% +$111K ﹤0.01% 5291
2018
Q1 		$58K Buy
50
+19
+61% +$21K ﹤0.01% 6050
2017
Q4 		$28K Buy
31
+26
+520% +$24K ﹤0.01% 6553
2017
Q3 		$5K Sell
5
-39
-89% -$44.4K ﹤0.01% 6874
2017
Q2 		$51K Sell
44
-30
-41% -$36.5K ﹤0.01% 5781
2017
Q1 		$85K Buy
74
+69
+1,380% +$66.6K ﹤0.01% 5326
2016
Q4 		$5K Hold
5
– – ﹤0.01% 6942
2016
Q3 		$2K Sell
5
-93
-95% -$37.9K ﹤0.01% 6942
2016
Q2 		$41K Buy
98
+93
+1,860% +$45.5K ﹤0.01% 5696
2016
Q1 		$2K Sell
5
-1
-17% -$386 ﹤0.01% 7236
2015
Q4 		$4K Sell
6
-784
-99% -$549K ﹤0.01% 7137
2015
Q3 		$703K Buy
790
+154
+24% +$140K ﹤0.01% 3421
2015
Q2 		$656K Buy
636
+630
+10,500% +$738K ﹤0.01% 3462
2015
Q1 		$9K Buy
+6
New +$7.61K ﹤0.01% 6515
2014
Q2 		– Sell
-5
Closed -$8K – 7387
2014
Q1 		$8K Sell
5
-5
-50% -$10.5K ﹤0.01% 6444
2013
Q4 		$12K Buy
+10
New +$16K ﹤0.01% 6367

Other funds holding HSTO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
MIH
Meitav Investment House Bene-Beraq, Israel $9.12B AUM 42.07% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
UCFA
United Capital Financial Advisors Irving, Texas $16.3B AUM 16.34% 1-Year Est. Return
N
Natixis Paris, France $28B AUM 26.79% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Citigroup's HSTO Position: Q3 2021 in Review

Citigroup sold out of Histogen Inc. Common Stock (HSTO) in Q3 2021, closing a stake of 5 shares.

Citigroup first reported a position in HSTO in Q4 2013 and held it in 28 quarters. The position peaked at $703K in Q3 2015. 22 funds tracked by Wall St. Rank hold HSTO as of Q3 2021.

  • Citigroup reported no remaining Histogen Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
  • Citigroup sold 5 Histogen Inc. Common Stock shares in Q3 2021.
  • Citigroup first reported a position in Histogen Inc. Common Stock in Q4 2013 and held it in 28 quarters.
  • Citigroup's Histogen Inc. Common Stock position peaked at $703K in Q3 2015.
  • 22 funds tracked by Wall St. Rank held Histogen Inc. Common Stock as of Q3 2021.

Based on Citigroup's 13F filing for Q3 2021, filed 10 Nov 2021.